SG11202012473UA - Ophthalmic compositions and methods for the treatment of eye disorders - Google Patents

Ophthalmic compositions and methods for the treatment of eye disorders

Info

Publication number
SG11202012473UA
SG11202012473UA SG11202012473UA SG11202012473UA SG11202012473UA SG 11202012473U A SG11202012473U A SG 11202012473UA SG 11202012473U A SG11202012473U A SG 11202012473UA SG 11202012473U A SG11202012473U A SG 11202012473UA SG 11202012473U A SG11202012473U A SG 11202012473UA
Authority
SG
Singapore
Prior art keywords
treatment
methods
ophthalmic compositions
eye disorders
disorders
Prior art date
Application number
SG11202012473UA
Other languages
English (en)
Inventor
Mahesh Kandula
Original Assignee
Cellix Bio Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellix Bio Private Ltd filed Critical Cellix Bio Private Ltd
Publication of SG11202012473UA publication Critical patent/SG11202012473UA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J33/00Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/10Quaternary compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/04Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0088Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11202012473UA 2018-06-27 2019-06-18 Ophthalmic compositions and methods for the treatment of eye disorders SG11202012473UA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN201841024038 2018-06-27
IN201841024496 2018-07-01
IN201841028857 2018-07-31
PCT/IB2019/055086 WO2020003051A1 (en) 2018-06-27 2019-06-18 Ophthalmic compositions and methods for the treatment of eye disorders

Publications (1)

Publication Number Publication Date
SG11202012473UA true SG11202012473UA (en) 2021-01-28

Family

ID=68984462

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202012473UA SG11202012473UA (en) 2018-06-27 2019-06-18 Ophthalmic compositions and methods for the treatment of eye disorders

Country Status (6)

Country Link
US (1) US20210277050A1 (de)
EP (1) EP3813794A4 (de)
AU (1) AU2019293958A1 (de)
CA (1) CA3104234A1 (de)
SG (1) SG11202012473UA (de)
WO (1) WO2020003051A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3228646A1 (en) * 2021-08-18 2023-02-23 Yandong Wang Application of steroid compound in preparation of drug for preventing and/or treating eye floaters
WO2023198192A1 (zh) * 2022-04-15 2023-10-19 广州润尔眼科生物科技有限公司 甾体化合物在制备预防和/或治疗老花眼的药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10398709B2 (en) * 2015-07-27 2019-09-03 Catacore, Inc. Compositions for the treatment of cataracts
CN108350021A (zh) * 2015-09-08 2018-07-31 视点医疗公司 用于治疗眼科疾病的化合物和制剂
CA3078680A1 (en) * 2017-11-17 2019-05-23 Mahmood Piraee Combinations of lanosterol or 25-hydroxycholesterol including derivatives thereof useful in the treatment of lens disorders

Also Published As

Publication number Publication date
US20210277050A1 (en) 2021-09-09
EP3813794A4 (de) 2022-07-13
EP3813794A1 (de) 2021-05-05
WO2020003051A1 (en) 2020-01-02
AU2019293958A1 (en) 2021-02-04
CA3104234A1 (en) 2020-01-02

Similar Documents

Publication Publication Date Title
ZA202002066B (en) Compositions and methods for the treatment of eye disorders
EP3463315C0 (de) Zusammensetzungen und verfahren zur verwendung von nintedanib zur behandlung von augenerkrankungen mit abnormaler neovaskularisation
IL282624A (en) Methods and compositions for the treatment of sight beard, mydriasis and other disorders of the eyes
IL287280A (en) Compounds and methods for the treatment of ocular disorders
SG11202103033WA (en) Compositions and methods for the treatment of presbyopia
IL287264A (en) Compounds and methods for the treatment of ocular disorders
IL275985A (en) Preparations and methods for the treatment of retinal disorders
ZA202002991B (en) Methods and compositions for assessing and treating intraocular diseases and disorders
IL287594A (en) Compositions and methods for the treatment of retinal degeneration
IL273531A (en) Ophthalmic preparations containing latanoprost for use in the treatment of eye diseases
EP3713553A4 (de) Zusammensetzungen und verfahren zur behandlung von augenkrankheiten
ZA202002075B (en) Compounds, compositions and methods for treatment of eye disorders and skin diseases
IL269400A (en) Medicines and preparations for the treatment of eye disorders
SG11202012473UA (en) Ophthalmic compositions and methods for the treatment of eye disorders
EP3697354A4 (de) Zusammensetzungen und verfahren zur behandlung von augenerkrankungen
IL280588A (en) Ophthalmic compositions and methods for treating eye problems and skin diseases
IL282898A (en) Ophthalmic compounds and methods for treating skin and eye diseases
EP3658217A4 (de) Behandlung von augenerkrankungen
EP4069220A4 (de) Ophthalmische formulierungen zur behandlung von presbyopie
EP3802491C0 (de) Fotochrome verbindungen zur verwendung bei der behandlung von augenerkrankungen
EP3658218A4 (de) Behandlung von augenerkrankungen
AU2017902346A0 (en) Methods of treating ocular disorders
AU2017904032A0 (en) Implants for the Treatment of Diseases and Disorders
EP3129054A4 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen und -störungen